BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38182693)

  • 1. Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.
    Wu W; Li Y; Wu X; Liang J; You W; He X; Feng Q; Li T; Jia X
    Funct Integr Genomics; 2024 Jan; 24(1):5. PubMed ID: 38182693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningioma-associated protein 30 accelerates the proliferation and invasion of hepatocellular carcinoma by modulating Wnt/GSK-3β/β-catenin signaling.
    Zhang Y; Li H; Wang J; Geng X; Hai J
    J Bioenerg Biomembr; 2021 Feb; 53(1):73-83. PubMed ID: 33405049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
    Jiang J; Xu B; Zheng Y; Guo X; Chen F
    Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAIR1-mediated resistance of hepatocellular carcinoma cells to T cells through a GSK-3β/β-catenin/MYC/PD-L1 pathway.
    Pan B; Ke X; Qiu J; Ye D; Zhang Z; Zhang X; Luo Y; Yao Y; Wu X; Wang X; Tang N
    Cell Signal; 2024 Mar; 115():111039. PubMed ID: 38199599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling.
    Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
    Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):845-853. PubMed ID: 31168819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway.
    Xu H; Li B
    Bioengineered; 2022 May; 13(5):12876-12887. PubMed ID: 35609318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting β-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma.
    Zhou Z; Li X; Yang G; Wang J; Li B; Huang Y; Yan J; Tao K
    Theranostics; 2023; 13(10):3371-3386. PubMed ID: 37351175
    [No Abstract]   [Full Text] [Related]  

  • 16. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
    Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
    J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
    Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF
    J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
    Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma.
    Gao ZX; Zhang ZS; Qin J; Zhang MZ; Cao JL; Li YY; Wang MQ; Hou LL; Fang D; Xie SQ
    Phytomedicine; 2023 Apr; 112():154715. PubMed ID: 36821999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.